Allied Market Research

2024

Retinoic Acid Market

Retinoic Acid Market Size, Share, Competitive Landscape and Trend Analysis Report by Mode of Administration and by End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Retinoic acid is a metabolite of vitamin A (retinol) that mediates the functions of vitamin A required for growth and development. It is a member of family of retinoids, that are compound either derived from vitamin A or are structurally similar to it.

Rise in incidences of cancers as retinoids find an important application in cancer therapeutics drive the market. In addition, retinoic acid is widely used for the treatment of photoaged skin, psoriasis, skin lesions of Kaposis sarcoma, and for cancers of breast and prostate also fuel the market growth. However, isotretinoin; a form of retinoic acid; is highly teratogenic.

As teratogenic drug can disturb the development of an embryo, therefore the use of retinoic acid is strictly controlled. This restrains the market growth. Conversely, increase in research for the cure of cancers and advancements in cancer therapeutics provide ample opportunities for the market growth.

The retinoic acid market is segmented on the basis of mode of administration, end user, and region. Based on mode of administration, the market is categorized into oral retinoids and external retinoids. By end user, it is classified into hospital pharmacy, retail pharmacy, and online pharmacy. By geography, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

The key players operating in the market include LGM Pharma, GF Health Products, Inc., GYMA Laboratories of America, Inc., Genemed Synthesis Inc., IMCoPharma a. s., Chongqing Huabang Pharmacy Co., Ltd., Olon S.p.A., and Sun Pharmaceutical Industries Ltd.

Key Benefits

  • The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
  • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
  • Key players are profiled and their strategies are analyzed thoroughly, which explains the competitive outlook of the global market.
  • The report offers a quantitative analysis¬†to enable the stakeholders to capitalize on the prevailing market opportunities.

Retinoic Acid Market Report Highlights

Aspects Details
Retinoic Acid Market By Mode of Administration
By Mode of Administration
  • Oral
  • External
Retinoic Acid Market By End User
By End User
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
Retinoic Acid Market By Region
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players
Key Market Players

GYMA Laboratories of America, Inc., Sun Pharmaceutical Industries Ltd., Genemed Synthesis Inc., Olon S.p.A., GF Health Products, Inc., The Derma Company, Mama Earth, LGM Pharma, IMCoPharma a. s., Chongqing Huabang Pharmacy Co., Ltd.

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Retinoic Acid Market

Global Opportunity Analysis and Industry Forecast, 2023-2032